文献速递其他结缔组织病

幼年系统性硬化症疾病严重度进展的独特轨迹

Distinct trajectories of disease severity progression in juvenile systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2026-10-20

基线J4S>7.5、发病至治疗启动>9个月及>1.5个器官受累为不良预后预测因素,且潜在轨迹类别与临床亚型一致性良好(κ=0.660)。

要点

  • JSSc存在两种严重度进展轨迹:低严重度反应好型与活动性进展预后差型。
  • 基线J4S>7.5、治疗延迟>9个月及>1.5个器官受累预示更严重病程。
  • 纤维化型和局限皮肤型PFS保持80-100%,弥漫型和 sine scleroderma 型分别降至54%和25%。

核心结论

  • JSSc可识别出两种具有明确预后意义的潜在疾病严重度类别。
  • 高基线J4S、延迟治疗及更多器官受累预测更严重的疾病病程。

主要发现

  • 纤维化型和局限皮肤型JSSc亚型无进展生存率(PFS)在观察期内保持80-100%。
  • 弥漫型和 sine scleroderma 亚型PFS分别降至54%和25%。
  • 识别出两个潜在类别:Class 1低严重度且治疗反应好,Class 2活动性进展且长期预后差。
  • 潜在轨迹类别与JSSc临床亚型一致性良好(κ=0.660)。

关键数值与推荐

  • 不良结局基线预测因素:J4S>7.5、发病至治疗启动>9个月、>1.5个器官受累。
  • 主要结局为无进展生存(PFS),定义为J4S随时间变化的百分比变化。

临床怎么用

  • 对基线J4S>7.5、发病至治疗启动>9个月或>1.5个器官受累的JSSc患者应警惕更严重病程。
  • 潜在轨迹类别与临床亚型一致性良好,可辅助早期风险分层与精准治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Juvenile systemic sclerosis (JSSc) often presents with overlapping features, making phenotypic classification and disease progression difficult to define. This study investigated whether JSSc comprises latent disease severity subgroups with distinct longitudinal trajectories and examined baseline predictors of class membership. METHODS: Retrospective cohort study using prospectively collected data from 45 patients with JSSc between January 2005 and December 2024. Demographic, clinical, laboratory, and disease severity data were collected. The primary outcome was progression-free survival (PFS), defined as percentage change in the Juvenile Systemic Sclerosis Severity score (J4S) over time. A Growth Mixture Model identified latent disease severity classes with distinct longitudinal trajectories and their baseline predictors. RESULTS: Thirty-eight JSSc patients (66% females), followed for ≥48 months, entered the study. PFS remained high in the fibrotic and limited cutaneous JSSc subtypes (80-100%) over the observation period, whereas the diffuse and sine scleroderma subtypes showed marked deterioration, with PFS decreasing to 54% and 25%, respectively. We identified two latent classes of disease severity: Class 1 showed low severity and good treatment response, Class 2 showed an active, progressive course with poor long-term outcomes. Baseline predictors of poor outcome were J4S >7.5, treatment initiation >9 months from disease onset, and >1.5 organs involved. Latent trajectory classes showed good concordance with JSSc clinical subtypes (κ = 0.660). CONCLUSION: We identified two latent classes of disease severity in JSSc with clear prognostic significance. High baseline J4S, delayed treatment, and greater organ involvement predicted a more severe disease course, paving the way for precision health strategies and optimized.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zulian F, Tirelli F, Castaldi B, et al. Distinct trajectories of disease severity progression in juvenile systemic sclerosis. Rheumatology (Oxford). 2026. PMID: 42899404. doi:10.1093/rheumatology/keag584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。